On Nov. 1, the D.C. Council unanimously passed B21-0210, which includes many improvements to the medical marijuana program, such as: 1) independent laboratory testing will be required, to ensure patients know what they are purchasing; and 2) advanced practice registered nurses, physician assistants, dentists, and naturopathic physicians, in addition to M.D.s, will be able to recommend medical cannabis.
A few changes were made before the final vote on the bill. One of these was the adoption of Councilmember Grosso’s amendment (initially supported only by Councilmember Robert White) to make the medical marijuana industry more inclusive. Previously, all individuals with a felony conviction or a misdemeanor drug conviction were barred from the industry, disproportionately impacting African Americans, who were more likely to be arrested for drug possession than whites despite similar usage rates. Now, individuals with misdemeanor drug convictions or felony convictions for possession with intent to distribute marijuana will no longer be barred.
There are other provisions that require D.C. to implement an electronic tracking system for medical marijuana purchased in the District before they can take effect. Then, patients will be allowed to visit whichever dispensaries they choose — instead of being limited to one — and patients enrolled in another state’s medical program will be allowed to visit dispensaries in D.C.